TEKY yields 0.28% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, TEKY + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TEKY + MRK for your $10,000?
TEKY invests globally in companies at the forefront in developing or enabling next-generation technologies, particularly artificial intelligence (AI). The fund targets approximately 40 to 60 companies across three segments: hardware infrastructure, enabling technologies, and AI application vendors. A proprietary data science platform is used to screen and rank potential securities based on their business exposure to AI, considering factors like product offerings, intellectual property, R&D efforts, revenue, and market presence. From this universe, a bottom-up stock selection process is employed, using tailored valuations approaches, revenue-based for early-stage firms and EV/EBITDA for established businesses. Investments include common and preferred stocks, ADRs, GDRs, warrants, rights, and participatory notes. Additionally, it may use futures and swaps for hedging or enhancing returns. The fund may hedge foreign currency exposure through forward contracts, depending on market conditions.
Full TEKY Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.